Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. Aging Knowl. Environ., 21 April 2004
Vol. 2004, Issue 16, p. or9

OTHER RESOURCES

ABAD Directly Links A{beta} to Mitochondrial Toxicity in Alzheimer's Disease

Joyce W. Lustbader, Maurizio Cirilli, Chang Lin, Hong Wei Xu, Kazuhiro Takuma, Ning Wang, Casper Caspersen, Xi Chen, Susan Pollak, Michael Chaney, Fabrizio Trinchese, Shumin Liu, Frank Gunn-Moore, Lih-Fen Lue, Douglas G. Walker, Periannan Kuppusamy, Zay L. Zewier, Ottavio Arancio, David Stern, Shirley ShiDu Yan, and Hao Wu

http://sageke.sciencemag.org/cgi/content/abstract/2004/16/or9

Abstract: Science 304, 448-452 (2004).

Mitochondrial dysfunction is a hallmark of {beta}-amyloid (A{beta})-induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that A{beta}-binding alcohol dehydrogenase (ABAD) is a direct molecular link from A{beta} to mitochondrial toxicity. A{beta} interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of A{beta}-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-A{beta} interaction and suppresses A{beta}-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an A{beta}-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-A{beta} interaction may be a therapeutic target in AD.

Abstract/Full Text







ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products


Science of Aging Knowledge Environment. ISSN 1539-6150